Zoledronic acid monohydrate
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 165800-06-6
Synonym(S): P,P′-[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic acid monohydrate, Zoledronate monohydrate, [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid) monohydrate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 15 MG | Y0002020-15-MG | In Stock | ₹ 14,072.50 |
Y0002020 - 15 MG
In Stock
Quantity
1
Base Price: ₹ 14,072.50
GST (18%): ₹ 2,533.05
Total Price: ₹ 16,605.55
grade
pharmaceutical primary standard
API family
zoledronic acid
manufacturer/tradename
EDQM
storage temp.
2-8°C
SMILES string
O.OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O
InChI
1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2
InChI key
FUXFIVRTGHOMSO-UHFFFAOYSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Zoledronic acid monohydrate >=98% (HPLC) | 165800-06-6 | MFCD08448695 | 10MG | -- | ₹ 12,538.32 | ||
Sigma Aldrich Fine Chemicals Biosciences Zoledronic acid monohydrate >=98% (HPLC) | 165800-06-6 | MFCD08448695 | 50MG | -- | ₹ 49,555.20 | ||
Sigma Aldrich Fine Chemicals Biosciences Zoledronic acid United States Pharmacopeia (USP) Reference Standard | 165800-06-6 | MFCD08448695 | 150MG | -- | ₹ 47,632.80 | ||
Enzo Life Sciences Zoledronic acid (1g). CAS: 165800-06-6 | -- | ₹ 78,149.12 | ||
Enzo Life Sciences Zoledronic acid (100mg). CAS: 165800-06-6 | -- | ₹ 35,720.15 | ||
Zoledronic Acid | -- | ₹ 27,279.00 | ||
Zoledronic acid | -- | ₹ 40,756.13 | ||
Phosphonic acid, P,P'-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-, hydrate (1:1) | -- | ₹ 890.00 - ₹ 24,119.00 | ||
Zoledronic acid monohydrate | -- | ₹ 6,497.00 - ₹ 22,606.00 | ||
165800-06-6 | Zoledronic acid hydrate | -- | ₹ 890.00 - ₹ 63,813.00 |
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Zoledronic acid monohydrate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Zoledronic acid (zoledronate) is a bisphosphonate bone resorption inhibitor, an inhibitor of farnesyl diphosphate (FPP) synthase which results in downstream inhibition of osteoclast activity and reduced bone resorption and turnover. It has been used to treat postmenopausal osteoporosis, Paget′s disease, hypercalcemia, and along with cancer chemotherapy to treat bone damage caused by cancer that has spread to the bones.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable